SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77844.52
114 (-0.15%)

Filter

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Alkem Laboratories Ltd.	Q V+ PT	66,240 Mid Cap	5,590.85 (0.92%)	30.19	4.64	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Viyash Scientific Ltd.	Q V PT	9,596 Small Cap	221.80 (0.98%)	124.93	10.67	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Granules India Ltd.	Q V+ PT	18,237 Small Cap	743.35 (1.01%)	45.52	4.15	5.58	-0.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Strides Pharma Science Ltd.	Q V+ PT	10,127 Small Cap	1,144.55 (4.17%)	55.22	3.07	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Glenmark Pharmaceuticals Ltd.	Q V+ PT	66,987 Mid Cap	2,371.05 (-0.11%)	62.89	6.71	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Procter & Gamble Health Ltd.	Q V PT	8,854 Small Cap	5,314.25 (-0.37%)	30.17	12.7	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Hikal Ltd.	Q V+ PT	2,609 Small Cap	213.20 (0.76%)	N/A	2.2	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	41,069 Mid Cap	2,478.95 (2.25%)	40.22	20.5	3.06	33.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Biocon Ltd.	Q V PT	61,716 Mid Cap	382.60 (0.49%)	8340.01	2.29	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Pfizer Ltd.	Q V PT	21,876 Small Cap	4,749.60 (-0.67%)	25.63	5.48	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Wockhardt Ltd.	Q V+ PT	27,953 Small Cap	1,636.75 (-4.85%)	131.23	5.66	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Laxmi Dental Ltd.	Q V PT	1,177 Small Cap	217.55 (1.56%)	91.24	4.96	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	2,816 Small Cap	97.88 (2.01%)	24.3	1.59	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	CORONA Remedies Ltd.	Q V+ PT	10,682 Small Cap	1,738.30 (-0.48%)	71.67	15.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Park Medi World Ltd.	Q V PT	10,589 Small Cap	246.10 (0.39%)	1474.97	11.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Krsnaa Diagnostics Ltd.	Q V PT	1,979 Small Cap	605 (-0.84%)	24.62	2.11	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Senores Pharmaceuticals Ltd.	Q V+ PT	4,229 Small Cap	932.45 (1.54%)	306.7	5.9	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Onesource Specialty Pharma Ltd.	Q V PT	19,979 Small Cap	1,816.55 (4.24%)	114.42	3.37	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Aarti Pharmalabs Ltd.	Q V+ PT	7,148 Small Cap	776.60 (-1.51%)	33.27	3.67	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Piramal Pharma Ltd.	Q V PT	21,946 Small Cap	183.85 (11.36%)	31.35	2.69	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Nephrocare Health Services Ltd.	Q V+ PT	5,365 Small Cap	546.10 (2.14%)	156.7	5.93	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	973 Small Cap	130.90 (6.03%)	669.59	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Blue Jet Healthcare Ltd.	Q V PT	8,472 Small Cap	491.25 (0.58%)	28.86	6.54	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Fabtech Technologies Ltd.	Q V PT	731 Small Cap	165.50 (0.58%)	30.16	1.88	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,728 Small Cap	4,759.55 (2.18%)	41.6	23.74	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Solara Active Pharma Sciences Ltd.	Q V PT	2,473 Small Cap	515.85 (0.50%)	N/A	1.99	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,097 Small Cap	166.95 (6.30%)	N/A	-11.88	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,11,527 Large Cap	7,837.85 (1.05%)	77.25	11.5	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Aurobindo Pharma Ltd.	Q V+ PT	86,156 Mid Cap	1,478.55 (-0.33%)	40.43	3.91	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Novartis India Ltd.	Q V+ PT	2,594 Small Cap	1,065.45 (1.40%)	26.68	3.28	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Piramal Pharma	183.85	11.36%
Indoco Remedies	251.25	10.22%
Nectar Lifesciences	13.59	9.95%
Sun Pharma Adv. Res	166.95	6.30%
Guj. Kidney & Super	130.90	6.03%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Wockhardt	1,636.75	-4.85%
Rubicon Research	951.90	-4.72%
Wanbury	252	-2.25%
Concord Biotech	1,197.15	-2.12%
Aarti Pharmalabs	776.60	-1.51%

News about Top Pharma Companies in India

May, 2026

Aurobindo Pharma zooms after getting EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma gets EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) inspected Aurobindo Pharma’s Unit-VII, an oral solid dosage manufacturing unit, situated at Special Economic Zone (Pharma), TSIIC, Green Industrial Park, Polepally Village, Jedcherla Mandal, Mahaboobnagar District, 509302, Telangana from January 28 to February 10, 2026. At the end of the inspection, a ‘Form 483’ was issued with a total of 9 observations. The Unit has now received Establishment Inspection Report (EIR) classifying the facility as ‘Voluntary Action Indicated’ (‘VAI’). FDA has concluded that this inspection is now closed.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Sanofi Consumer Healthcare India informs about disclosures

Sanofi Consumer Healthcare India has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Wockhardt - Quaterly Results

A decent increase of about 45.35% in the sales to Rs. 5160.00 millions was observed for the quarter ended March 2026. The sales figure stood at Rs. 3550.00 millions during the year-ago period.Net Profit for the quarter ended March 2026 zoomed to 317.50% from Rs. 400.00 millions to Rs. 1670.00 millions.The company reported a good operating profit of 2160.00 millions compared to 1200.00 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	5160.00	3550.00	45.35	17390.00	14020.00	24.04	17390.00	14020.00	24.04
Other Income	550.00	140.00	292.86	1370.00	550.00	149.09	1370.00	550.00	149.09
PBIDT	2160.00	1200.00	80.00	6540.00	3550.00	84.23	6540.00	3550.00	84.23
Interest	410.00	400.00	2.50	1760.00	1990.00	-11.56	1760.00	1990.00	-11.56
PBDT	2100.00	800.00	162.50	5030.00	1560.00	222.44	5030.00	1560.00	222.44
Depreciation	430.00	400.00	7.50	1860.00	1680.00	10.71	1860.00	1680.00	10.71
PBT	1670.00	400.00	317.50	3170.00	-120.00	-2741.67	3170.00	-120.00	-2741.67
TAX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	1670.00	400.00	317.50	3170.00	-120.00	-2741.67	3170.00	-120.00	-2741.67
Equity	810.00	810.00	0.00	810.00	810.00	0.00	810.00	810.00	0.00
PBIDTM(%)	41.86	33.80	23.84	37.61	25.32	48.52	37.61	25.32	48.52

May, 2026

Wockhardt informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Wockhardt has enclosed Press Release on the Audited Financial Results (Standalone and Consolidated) for the quarter and the financial year ended 31st March, 2026. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Health X Platform Ltd.	907 Crore
2	Fischer Medical Ventures Ltd.	2,506 Crore
3	3B Blackbio Dx Ltd.	1,129 Crore
4	Max Healthcare Institute Ltd.	98,852 Crore
5	Indegene Ltd.	12,835 Crore
6	Acutaas Chemicals Ltd.	21,963 Crore
7	Rubicon Research Ltd.	16,494 Crore
8	Yatharth Hospital & Trauma Care Services Ltd.	7,923 Crore
9	Dr. Agarwals Health Care Ltd.	14,521 Crore
10	Sigachi Industries Ltd.	765 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,692	55,876	36.66	12.74	25.65	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,359	1,47,478	64.91	16.23	36.68	26.68
Ajanta Pharma Ltd. (S)	Very Good	3,080	38,646	36.60	8.54	24.73	24.45
Lupin Ltd. (M)	Somewhat Good	2,460	1,11,668	24.04	5.37	14.31	20.83
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,206	63,517	92.14
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,371	66,987	68.93
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	42.38
Wockhardt Ltd. (S)	Not Good	1,637	27,953	39.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,359	1,47,478	33.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	47.25	8.81	29.84	17.81
Mankind Pharma Ltd. (M)	Very Good	2,375	97,506	57.24	6.11	34.36	14.65
Laurus Labs Ltd. (M)	Very Good	1,206	63,517	71.46	11.98	35.90	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	13.26
Ajanta Pharma Ltd. (S)	Very Good	3,080	38,646	36.60	8.54	24.73	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	30.57
Cipla Ltd. (L)	Very Good	1,363	1,10,283	24.26	3.28	14.63	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,834	4,43,973	40.67	5.47	22.24	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	47.25	8.81	29.84	19.45

You’ve reached your free data limit. Unlock unlimited data views for free. Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Aurobindo Pharma zooms after getting EIR for Telangana unit

Aurobindo Pharma gets EIR for Telangana unit

Aurobindo Pharma informs about updates

Sanofi Consumer Healthcare India informs about disclosures

Wockhardt - Quaterly Results

Wockhardt informs about press release

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.